Top compounds associated with response to SPRY1


Feature Type Standardized
Nominal ANOVA
mRNA BRD9647 CTRPv2 pan-cancer AAC 0.045 0.2
mRNA BRD-K64610608 CTRPv2 pan-cancer AAC 0.047 0.2
mRNA BRD-K99584050 CTRPv2 pan-cancer AAC -0.062 0.2
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.042 0.3
mRNA Bortezomib GDSC1000 pan-cancer AAC 0.06 0.3
mRNA VX-680 GDSC1000 pan-cancer AAC 0.064 0.3
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.041 0.3
mRNA SJ-172550 CTRPv2 pan-cancer AAC 0.045 0.3
mRNA KU-60019 CTRPv2 pan-cancer AAC 0.041 0.3
mRNA Vorinostat CTRPv2 pan-cancer AAC 0.039 0.3
Download CSV